Related Experiment Video
Updated: Mar 9, 2026

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
Danger-associated molecular patterns in Alzheimer's disease
Carmen Venegas1, Michael T Heneka2,3
1Department of Neurodegenerative Disease and Gerontopsychiatry, University of Bonn, Bonn, Germany; and.
Danger-associated molecular patterns (DAMPs) signal danger to the innate immune system, activating inflammatory responses. This study highlights DAMPs
Area of Science:
- Neuroimmunology
- Molecular Biology
- Cellular Biology
Background:
- Innate immunity relies on pattern recognition receptors (PRRs) to detect pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs).
- DAMPs and PAMPs initiate proinflammatory cascades and inflammasome activation, leading to cytokine release.
- Alzheimer disease (AD) is a prevalent neurodegenerative disorder with an emerging link to innate immune activation.
Purpose of the Study:
- To elucidate the role of DAMPs in innate immune activation within Alzheimer disease.
- To identify specific DAMPs implicated in AD pathogenesis.
Main Methods:
- Review of existing literature on DAMPs and Alzheimer disease.
- Analysis of signaling pathways involving PRRs and DAMPs.
Main Results:
- Amyloid beta (Aβ), high-mobility group box 1 (HMGB1), S100 proteins, chromogranin A, and nucleic acids are identified as key DAMPs in AD.
- These DAMPs contribute to the innate immune response in the AD brain.
- DAMPs activate signal transduction pathways and inflammasomes, promoting neuroinflammation.
Conclusions:
- DAMPs play a critical role in mediating innate immune activation in Alzheimer disease.
- Understanding DAMPs' function in AD offers potential therapeutic targets for neuroinflammation.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
08:25Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Dementia
The progression of dementia is generally gradual....